Correlation Between Tempest Therapeutics and Entera Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Entera Bio, you can compare the effects of market volatilities on Tempest Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Entera Bio.

Diversification Opportunities for Tempest Therapeutics and Entera Bio

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tempest and Entera is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Entera Bio go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Entera Bio

Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 0.71 times more return on investment than Entera Bio. However, Tempest Therapeutics is 1.41 times less risky than Entera Bio. It trades about 0.15 of its potential returns per unit of risk. Entera Bio is currently generating about 0.06 per unit of risk. If you would invest  86.00  in Tempest Therapeutics on November 2, 2024 and sell it today you would earn a total of  9.00  from holding Tempest Therapeutics or generate 10.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tempest Therapeutics  vs.  Entera Bio

 Performance 
       Timeline  
Tempest Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Tempest Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tempest Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Entera Bio 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Entera Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Entera Bio showed solid returns over the last few months and may actually be approaching a breakup point.

Tempest Therapeutics and Entera Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tempest Therapeutics and Entera Bio

The main advantage of trading using opposite Tempest Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.
The idea behind Tempest Therapeutics and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon